BMPR2 and pulmonary arterial hypertension: Ranchoux et al. found that serum soluble CD14 was obviously higher in patients with idiopathic PAH and hereditary PAH carrying the BMPR2 mutation compared to control groups (Ranchoux et al., 2017).